PLUS1
41.57
-0.53 (-1.26%)
-0.53 (-1.26%)
Upgrade to Real-Time
Afterhours (Closed)
Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
|
|
Level 1 Starter
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Cassava Sciences Inc | SAVA | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded  |
|
|---|---|---|---|---|
| -0.53 | -1.26% | 41.57 | 19:44:58 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 41.69 | 40.80 | 42.27 | 41.57 | 42.10 |
| Bid Price | Ask Price | Spread | News | |
|---|---|---|---|---|
| 41.25 | 41.57 | 0.32 | - | - |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 8,998 | 597,427 | $ 41.42 | $ 24,747,768 | 2,693,419 | 1.11 - 117.54 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 19:59:42 | 1 | $ 41.57 | USD |
Cassava Sciences Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 1.45B | 34.95M | 33.13M | $ - | $ - | -0.27 | -51.50 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | 0.00% | - | - |
Cassava Sciences News
| Date | Time | Source | News Article |
|---|---|---|---|
| 3/31/2021 | 16:26 | Edgar (US Regulatory) | Proxy Statement (definitive) (def 14a) |
| 3/23/2021 | 17:06 | Edgar (US Regulatory) | Annual Report (10-k) |
| 3/23/2021 | 09:28 | Seeking Alpha | Cassava Sciences EPS misses by $0.04 |
| 3/23/2021 | 08:55 | Edgar (US Regulatory) | Current Report Filing (8-k) |
| 3/23/2021 | 08:30 | GlobeNewswire Inc. | Cassava Sciences Announces Full-year 2020 Financial Results.. |
| 3/19/2021 | 20:34 | TipRanks | Cassava: A Promising Yet Risky Alzheimer’s Pure Play |
| 3/18/2021 | 16:07 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) |
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical SAVA Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 47.45 | 47.68 | 40.35 | 42.72 | 987,791 | -5.88 | -12.39% |
| 1 Month | 52.44 | 63.65 | 40.35 | 53.10 | 2,015,011 | -10.87 | -20.73% |
| 3 Months | 10.38 | 117.54 | 9.9801 | 55.06 | 7,127,591 | 31.19 | 300.48% |
| 6 Months | 12.16 | 117.54 | 6.70 | 39.90 | 4,837,626 | 29.41 | 241.86% |
| 1 Year | 4.83 | 117.54 | 1.11 | 21.61 | 5,238,719 | 36.74 | 760.66% |
| 3 Years | 1.21 | 117.54 | 1.00 | 18.06 | 3,313,463 | 40.36 | 3,335.54% |
| 5 Years | 1.21 | 117.54 | 1.00 | 18.06 | 3,313,463 | 40.36 | 3,335.54% |
Cassava Sciences Description
| Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. It is also developing an experimental biomarker diagnostic PTI-125 to detect Alzheimer's disease with the help of a blood test. |
